Direkt zum Inhalt
Merck

A3234

Apolipoprotein E4 human

recombinant, expressed in E. coli, ≥90% (SDS-PAGE and HPLC), lyophilized powder

Synonym(e):

ApoE4

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Preise und Verfügbarkeit sind derzeit nicht verfügbar.

Über diesen Artikel

UNSPSC Code:
12352202
NACRES:
NA.32
MDL number:

Fortfahren mit

Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten

Produktname

Apolipoprotein E4 human, recombinant, expressed in E. coli, ≥90% (SDS-PAGE and HPLC), lyophilized powder

recombinant

expressed in E. coli

assay

≥90% (SDS-PAGE and HPLC)

form

lyophilized powder

UniProt accession no.

storage temp.

−20°C

Quality Level

Gene Information

human ... APOE(348)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel
MABN43SRP4760ALP70
assay

≥90% (SDS-PAGE and HPLC)

assay

-

assay

≥90% (HPLC), ≥90% (SDS-PAGE)

assay

≤95% (SDS-PAGE)

storage temp.

−20°C

storage temp.

-

storage temp.

−20°C

storage temp.

-

form

lyophilized powder

form

-

form

lyophilized

form

liquid

Quality Level

100

Quality Level

100

Quality Level

-

Quality Level

100

recombinant

expressed in E. coli

recombinant

-

recombinant

expressed in E. coli

recombinant

-

UniProt accession no.

P02649

UniProt accession no.

P02649

UniProt accession no.

P02649

UniProt accession no.

P02649

Biochem/physiol Actions

ApoE4 (apolipoprotein E4) is associated with AD (Alzheimer′s disease).[1]
Apolipoprotein E4 is a member of the apolipoprotein E family of plasma lipoproteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. ApoE4 regulates plasma lipid levels by increasing the degradation of particles rich in triglycerides and cholesterol. In addition to facilitating solubilization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, regulate the activity of enzymes involved in lipid metabolism and bind amyloid-β protein, the major component of plaques in Alzheimer′s disease, which it delivers to the microglia, the major scavenger cells of brain. Individuals heterozygous for the ApoE4 allele are at higher risk of late-onset Alzheimer′s disease. ApoE exists in three major isoforms: E2, E3, and E4, which differ from one another by a single amino-acid substitution. Recombinant human ApoE4 is a 34.4 kDa protein containing 300 amino acid residues.
The ApoE4 isoform of ApoE correlates with increased incidence of Alzheimer′s disease, and has been shown to regulate lipid metabolism and bind amyloid-beta. Recombinant ApoE4 retains full biological activity and can be used to study interactions of ApoE4 with amyloid-β, Tau, and LDLR.

General description

Apolipoprotein E (ApoE) is present in the brain and is mainly produced by astrocytes.[2] It is a 299 amino acid glycoprotein of 34kDa. It is present in all classes of lipoproteins except LDL (low-density lipoprotein).[3] APOE gene has three alleles, such as APOE ε3, APOE ε4 and APOE ε2.[2] It is located on human chromosome 19q13.[4]

Physical form

Lyophillized from a 0.2 μm filtered solution in 20 mM sodium phosphate, pH 7.8.

Lagerklasse

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models
Huang Y
Biochemical Society Transactions, 120(4), 702-736 (2011)
Traumatic Brain Injury
Neurobiology of Brain Disorders, 120(4), 219-235 (2015)
Lipids and disorders of lipoprotein metabolism
Clinical Biochemistry, 120(4), 702-736 (2014)
Twenty years of the Alzheimer?s disease amyloid hypothesis: a genetic perspective
Tanzi R E and Bertram L
Cell, 120(4), 545-555 (2005)
Fatemeh Nouri Emamzadeh et al.
Neuroscience letters, 618, 146-151 (2016-02-28)
Parkinson's disease is a progressive brain disorder due to the degeneration of dopaminergic neurons in the substantia nigra. The accumulation of aggregated forms of α-synuclein protein into Lewy bodies is one of the characteristic features of this disease although the

Verwandter Inhalt

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung